May 27, 2021

Proceedings from the second in a series of 11 integrated webinars held in association with the 2021 ONS Annual Congress. Featuring perspectives from Drs John V Heymach, Paul K Paik and Zofia Piotrowska on cases from the practices of Ms Kelly EH Goodwin, Ms Tara Plues and Ms Victoria Sherry, including the following topics:

• Introduction (0:00)
• Case Presentations Involving Targeted Therapy for Non-Small Cell Lung Cancer (NSCLC) (3:28)
• Case: A man in his mid-50s with newly diagnosed NSCLC with brain metastases and an EGFR exon 19 deletion — Kelly EH Goodwin, MSN, RN, ANP-BC (8:43)
• Case: A woman and oncologist in her late 50s with localized NSCLC and an EGFR tumor mutation — Victoria Sherry, DNP, CRNP, AOCNP (21:49)
• Case: A woman in her mid-60s with metastatic NSCLC with a HER2 mutation — PD-L1: 40% — Tara Plues, APRN, MSN (31:53)
• Case: A woman in her early 60s with newly diagnosed metastatic NSCLC and an ALK mutation — Ms Goodwin (39:15)
• Case: A woman in her mid-70s with multiple regimen-relapsed metastatic NSCLC and an ALK mutation — Ms Sherry (45:19)
• Case Presentations Involving Immunotherapy for NSCLC (57:31)
• Case: A man in his mid-60s with newly diagnosed metastatic adenocarcinoma of the lung — PD-L1: 95% — Ms Plues (58:00)
• Case: A woman in her late 50s with Stage IIIB NSCLC without actionable mutations — PD-L1: 0% — Ms Goodwin (1:13:44)

NCPD information and select publications